Lumos Pharma, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
LUMO on Nasdaq
Location
4200 Marathon Blvd., Suite 200, Austin, TX

Insiders trading volume in the past year

Lumos Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David B. Karpf Chief Medical Officer $26.6K Feb 1, 2023
Lota S. Zoth Director $0 Dec 12, 2024
Thomas A. Raffin Director $0 Dec 12, 2024
John C. McKew Chief Scientific Officer $0 -$13.9K -100% Dec 12, 2024
Richard Hawkins Chief Executive Officer, Director $0 Dec 12, 2024
Chad Allen Johnson Director $0 Dec 12, 2024
Kevin M. Lalande Director $0 Dec 12, 2024
Joseph S. McCracken Director $0 Dec 12, 2024
Aaron Schuchart Chief Business Officer $0 Dec 12, 2024
Lori D. Lawley Chief Financial Officer $0 Dec 12, 2024
An van Es-Johansson Director $0 Dec 12, 2024
Bradley J. Powers General Counsel $0 Dec 12, 2024
Pisit Duke Pitukcheewanont Chief Medical Officer $0 Dec 12, 2024

Recent Insider Transactions by Companies or Individuals for Lumos Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.